Keynote Financial Services’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
VCM
VPM
Keynote Financial Services's BMY Position: Q1 2026 in Review
Keynote Financial Services reduced its Bristol-Myers Squibb (BMY) stake by 0.83% in Q1 2026, selling an estimated $15.6K and leaving 32,025 shares worth $1.94M. The position accounts for 1.03% of the portfolio, ranked #20.
Keynote Financial Services first reported a position in BMY in Q1 2024 and has held it in 9 quarters since. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Keynote Financial Services held 32,025 shares of Bristol-Myers Squibb worth $1.94M as of Q1 2026.
- Keynote Financial Services sold 267 Bristol-Myers Squibb shares in Q1 2026, an estimated $15.6K.
- Bristol-Myers Squibb made up 1.03% of Keynote Financial Services's portfolio in Q1 2026, its #20 holding.
- Keynote Financial Services first reported a position in Bristol-Myers Squibb in Q1 2024 and has held it in 9 quarters since.
- 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Keynote Financial Services's 13F filing for Q1 2026, filed 13 May 2026.